Delivery Order SPE2DB20D6037-SPE2DB25FTWC5
Award Date 8/11/25
Potential Completion Date 8/12/25
Potential Value $2.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,764.80, is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $1,479.75, is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2023. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,906.39 contract is for the delivery of Micardis HCT 40-12.5 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,843.20 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, with a performance period ending on June 24, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $10,634.97 contract is for the delivery of Micardis HCT 80-25 mg tablet units to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 through...
- This federal contract award, with ID SPE2DB20D6037|SPE2DB25FTVB6, was issued by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a delivery order with a firm fixed price, valued at $2,804.80, and covers the provision of the pharmaceutical product MICARDIS HCT 40-12.5 MG TABLET UD 30S. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc....
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,425.24 firm fixed-price delivery order is for the supply of Micardis HCT 80-12.5 mg tablets, with a completion date of June 3, 2022. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, under the SPE2DB program. The $2,460.12 contract is for the delivery of Micardis HCT 40-12.5 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,367.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30-count). The award was issued on August 12, 2025, with an ultimate completion date of August 13, 2025, and does not utilize a set-aside designation. Performance will take place in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,483.05 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of LIS-HCTZ 20-12.5 1000S pharmaceutical products. This delivery order was issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract with the DLA, valued at up to $4,999,999 through 2025, which enables the DLA to order a broad range of pharmaceutical items to fulfill the...